Litcius/Paper detail

New PCSK9 inhibitor miR-552-3p reduces LDL-C via enhancing LDLR in high fat diet-fed mice

Ningning Ma, Lei Fan, Yunxia Dong, Xiaoding Xu, Chuwei Yu, Jing Chen, Jin Ren

2021Pharmacological Research28 citationsDOI

Topics & Concepts

PCSK9LDL receptorHyperlipidemiamicroRNAIn vivoChemistryTranscription (linguistics)Untranslated regionPharmacologyMessenger RNABiologyGeneCholesterolBiochemistryLipoproteinEndocrinologyGeneticsLinguisticsPhilosophyDiabetes mellitusRNA Research and SplicingLipoproteins and Cardiovascular HealthRNA and protein synthesis mechanisms
New PCSK9 inhibitor miR-552-3p reduces LDL-C via enhancing LDLR in high fat diet-fed mice | Litcius